We present our poster with VasoDynamics at Scotland’s Health R&I Conference
October 22, 2025
Pharmidex is delighted to announce our joint poster with
VasoDynamics Ltd at Scotland’s Health Research and Innovation Conference on October 23rd in Edinburgh!
We’re proud to be part of this inspiring event, organised by
NHS Scotland and
CSO Scotland, which brings together the brightest minds driving progress in health research, innovation, and life sciences.
📍 Visit our stand to learn more about our collaborative work. A printout of the poster will be available.
Mo Alavijeh (FRSC, FRSM) is looking forward to meeting attendees and discussing new opportunities for partnership and discovery.
Together with
VasoDynamics Ltd, we’re advancing science through collaboration and innovation.
🔗 Learn more about
Pharmidex:
www.pharmidex.com
#Pharmidex #VasoDynamics #HealthResearch #DrugDiscovery #Collaboration #Scotland #CSO_Scotland #NHSScotland #ScotHRIC25
Head of Respiratory at Pharmidex , Ian Knowles will be attending the Drug Delivery to the Lungs Conference (DDL) on 10–12 December 2025 at the Edinburgh International Conference Centre. DDL brings together global leaders in pulmonary and respiratory drug delivery, and Ian looks forward to meeting fellow attendees, exploring collaborations, and discussing how Pharmidex can support and accelerate drug discovery and development across industry and academia. If you’ll be there too, feel free to reach out we look forward to building new connections and advancing innovation together.
Pharmidex is pleased to announce that Dr. Mo Alavijeh (FRSC, FRSM) and Janette Dalay Robertson will attend the “Recent Clinical Candidates and SMR Award Meeting” this Thursday, 4 December 2025. If you’re attending, we’d be happy to connect!
Pharmidex is pleased to announce that Dr. Mo Alavijeh (FRSC, FRSM) , and our Dr. Ian Knowles , will attend Genesis 2025 this Wednesday, December 3rd, hosted by One Nucleus . They look forward to meeting fellow attendees, exploring new collaborations, and building partnerships with companies and academic groups to advance drug discovery and development. See you at Genesis 2025!
